Roadmap
2013 2019
2013
2013
ARNA Genomics was established
Obtained status of a member of the Skolkovo biomedical cluster
2014
2014
Seed round;
Development of ARNA-Thermometr, a test for the presence of oncological diseases;
“Know-how” objects formalization
2015
2015
Development of ARNA Breast Cancer — a high-precision test for early detection of breast cancer
2016
2016
Development of ARNA Colon Cancer;
ARNA BC development is completed;
Beginning of laboratory tests of ARNA BC;
Submission of patent application No 1
2017
2017
End of laboratory tests of ARNA BC;
Start of ARNA BC clinical research jointly with Sechenov University;
Submission of application of Patent Cooperation Treaty No 1;
Token Distribution Event
2018
2018
Opening of the office and the 1st laboratory unit in the USA. Submission of application of Patent Cooperation Treaty No 2 and 3. Agreement of the regulatory strategy for ARNA BC. Launch of clinical research No 1 in the USA with FDA. ARNA CC development is completed, starting laboratory research. ARNA Panacea – launch of the beta version of blockchain-ecosystem, basic documentation for develop
2019
2019
Using of ARNA Panacea’s blockchain ecosystem by interested market players (regulators, investors, users, etc.) Start of development: ARNA Lung, ARNA Liver, ARNA Pancreas; ARNA BC’s entry into the US market; Clinical trials in China; National phases: USA, China, India, EU, UK, Israel, Brazil; Seed round B; Receiving the first revenue.